# Ginkgo Bioworks (DNA) — Analyst Forecast

DNA · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/dna/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Sell | 1 | 0 | 2 | 3 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 13, 2026 | TD Cowen | Maintained | Hold | $11.00 |
| Sep 4, 2026 | BTIG | Maintained | Sell | $5.00 |
| Aug 7, 2026 | TD Cowen | Downgraded | Buy → Hold | $9.00 |
| Mar 12, 2026 | BTIG | Maintained | Sell | $5.00 |
| Jan 8, 2026 | TD Cowen | Maintained | Buy | $12.00 |
| Aug 25, 2025 | BTIG | Maintained | Sell | $9.00 |
| Sep 20, 2024 | TD Cowen | Maintained | Buy | $10.00 |
| Aug 23, 2024 | BTIG | Maintained | Sell | $7.00 |
| Jul 9, 2024 | Goldman Sachs | Maintained | Sell | $0.30 |
| Jun 26, 2024 | BTIG | Maintained | Sell | $0.20 |
| May 15, 2024 | Morgan Stanley | Maintained | Equal-Weight | $1.00 |
| May 15, 2024 | BTIG | Downgraded | Neutral → Sell | — |
| May 10, 2024 | William Blair | Downgraded | Market Perform → Underperform | — |
| Mar 1, 2024 | TD Cowen | Maintained | Outperform | $3.00 |
| Jan 23, 2024 | Goldman Sachs | Maintained | Sell | $1.10 |
| Jan 22, 2024 | Goldman Sachs | Maintained | Sell | $1.10 |
| Nov 15, 2023 | Raymond James | Downgraded | Outperform → Market Perform | $2.50 |
| Nov 14, 2023 | Raymond James | Downgraded | Outperform → Market Perform | $2.50 |
| Nov 9, 2023 | BTIG | Downgraded | Buy → Neutral | — |
| Jun 5, 2023 | Goldman Sachs | Maintained | Sell | $1.25 |

## Frequently Asked Questions

### Is DNA a buy, sell, or hold?

Analysts covering Ginkgo Bioworks currently average a Sell rating: 1 buy, 0 hold and 2 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on DNA?

On Oct 13, 2026, TD Cowen maintained Ginkgo Bioworks at Hold with a price target of $11.00.

## Similar Stocks

- [TWST](https://www.lighthorse.io/tickers/twst) — Twist Bioscience Corporation - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).